MarketTwits
268K subscribers
79.1K photos
3K videos
1.12K files
83.8K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

№ 4943378258
加入频道
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#IFRX +35% InflaRx N.V. -after reporting positive results from the open label extension part of the SHINE study for IFX-1 in hidradenitis suppurativa.

#DXCM +21% DexCom, Inc. -after the company posted upbeat Q3 results and raised FY2019 sales guidance.

#LXRX +16% Lexicon Pharmaceuticals, Inc. - following Q3 results.

#LVGO +13% Livongo Health, Inc. -after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 sales guidance and issued Q4 sales guidance above analyst estimates.

#EYE +13% National Vision Holdings, Inc. - following Q3 results.

#TXMD +10% TherapeuticsMD, Inc.

#SAIL +9% SailPoint Technologies Holdings, Inc. - reported better-than-expected Q3 EPS and sales results.

#ELF +9% e.l.f. Beauty, Inc. - after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY20 EPS and sales guidance.

#MT +8% ArcelorMittal - after the company reported Q3 results.

#SONO +8% Sonos, Inc.

#IQ +7% iQIYI, Inc. -reported better-than-expected Q3 EPS results.

#QCOM +6% QUALCOMM Incorporated - reported better-than-expected Q4 EPS and sales results.

#BIDU +6% Baidu, Inc. - reported better-than-expected Q3 EPS and sales results.

#MYOK +4% MyoKardia, Inc.

ВНИЗ

#PRTY -39% Party City Holdco Inc. -reported Q3 results.

#OBSV -30% ObsEva SA -said the results from the Phase 2 European confirmatory study of nolasiban in women undergoing embryo transfer following in-vitro fertilization did not meet the primary endpoint of an increase in ongoing pregnancy rate at 10 weeks.

#FOSL -28% Fossil Group, Inc. - reported Q3 EPS of $(0.51) compared to the $0.09 estimate and worse-than-expected sales results.

#RKDA -17% Arcadia Biosciences, Inc. - reported weaker-than-expected earnings for its third quarter.

#PBYI -15% Puma Biotechnology, Inc. - reported Q3 results.

#ROKU -14% Roku, Inc. -despite the company reporting better-than-expected Q3 EPS and sales results.

#EXPE -12% Expedia Group, Inc. - reported worse-than-expected Q3 EPS and sales results.

#INSG -11% Inseego Corp - reported worse-than-expected Q3 EPS results. The company also issued Q4 sales guidance below estimates.

#AGRX -11% Agile Therapeutics, Inc.

#VERI -10% Veritone, Inc. - reported Q3 results.

#HL -10% Hecla Mining Company - reported Q3 results.

#RP -10% RealPage, Inc. -reported Q3 results and to announced plans to acquire Buildium for $580 million in cash.

#RLGY -6% Realogy Holdings Corp. - reported worse-than-expected Q3 results and agreed to sell its global relocation business to SIRVA Worldwide, Inc.

#UPWK -6% Upwork Inc - narrowed the high end of FY19 sales guidance.

#CVNA -6% Carvana Co - reported Q3 earnings results.

#AGIO -5% Agios Pharmaceuticals Inc - reported a 7.5 million share common stock offering.
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#NKTR +9% Nektar Therapeutics - presented data from first-in-human Phase 1a study on Novel T regulatory cell stimulator, NKTR-358 at the ACR 2019.

#CANF +8% Can-Fite BioPharma Ltd. - was granted US Patent for piclidenoson in the treatment of osteoarthritis.

#MPW +8% Medical Properties Trust, Inc.

#PIR +6% Pier 1 Imports, Inc. -after dropping 7% on Friday.

#FOLD +6% Amicus Therapeutics, Inc. - reported upbeat earnings for its third quarter and raised the lower end of its Galafold revenue guidance.

#SPWR +6% SunPower Corporation - announced plans to split into two independent publicly-traded companies.

#EVH +6% Evolent Health, Inc. - after climbing 8% on Friday.

#MYOK +5% MyoKardia, Inc.

#IGLD +4% Internet Gold - Golden Lines Ltd. - after falling 12% on Friday.

#APPS +4% Digital Turbine, Inc.

#TEVA +4% Teva Pharmaceutical Industries Limited -after gaining 9% on Friday.

#PTCT +4% PTC Therapeutics, Inc. - said Risdiplam Pivotal SUNFISH study demonstrated statistically significant improvement for patients with Type 2/3 spinal muscular atrophy.

#INOV +3% Inovalon Holdings, Inc.

ВНИЗ

#NXTC -55% NextCure, Inc. - announced updated clinical data from NC318 Phase 1/2 clinical trial presented at the SITC 2019.

#FOMX -10% Foamix Pharmaceuticals Ltd. - Foamix Pharmaceuticals and Menlo Therapeutics Inc. #MNLO reported a merger agreement to create a combined biopharmaceutical company.

#TUP -6% Tupperware Brands Corporation - reported plans to suspend quarterly dividend.

#LITE -4% Lumentum Holdings Inc.

#X -3% United States Steel Corporation

#CNST -3% Constellation Pharmaceuticals, Inc.

#RIO -3% Rio Tinto Group